Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study

Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study

(2019) Jason C. Yam et al.   OPHTHALMOLOGY

Update in myopia and treatment strategy of atropine use in myopia control

(2018) Pei-Chang Wu et al.   EYE

Low-Concentration Atropine for Myopia Progression (LAMP) Study

(2018) Jason C. Yam et al.   OPHTHALMOLOGY

Efficacy and Adverse Effects of Atropine in Childhood Myopia

(2017) Qianwen Gong et al.   JAMA Ophthalmology

Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention

(2016) Alicja R Rudnicka et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

(2016) Audrey Chia et al.   OPHTHALMOLOGY

Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia

(2015) Tiana Y. Clark et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%

(2013) Audrey Chia et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms

(2013) Richard A. Stone et al.   EXPERIMENTAL EYE RESEARCH

Prevalence and Risk Factors for Myopic Retinopathy in a Japanese Population

(2012) Tomoko Asakuma et al.   OPHTHALMOLOGY

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)

(2011) Audrey Chia et al.   OPHTHALMOLOGY

Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2%pirenzepineophthalmicgelinchildrenwithmyopia

(2008) R. Michael Siatkowski et al.   JOURNAL OF AAPOS